511 Initial results of a phase 1 study of intratumoral ONCR-177, an oncolytic herpes-simplex virus-1 expressing five immunomodulatory transgenes, in subjects with advanced injectable tumors

• Robert Wesolowski,
• Igor Puzanov,
• Gerald Falchook,
• Erminia Massarelli,
• Anna Spreafico,
• Patrick Ott,
• Meredith McKean,
• Taofeek Owonikoko,
• Hatem Soliman,
• Laura Chow,
• Jong Chul Park,
• Christos Fountzilas,
• Corey Whalen,
• Adrienne Yanez,
• Christopher Dupont,
• Julia Auer,
• Tooba Cheema,
• John Goldberg,
• Ted Ashburn

Affiliations

Robert Wesolowski

Aff1 Division of Medical Oncology B401 Starling Loving Hall, W10th Avenue 43210 Columbus OH USA

Igor Puzanov

Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA

Gerald Falchook

Aff111 SCRI at HealthONE Denver CO USA

Erminia Massarelli

Aff23 grid.240145.60000000122914776University of Texas MD Anderson Cancer Center Houston TX USA

Anna Spreafico

Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Patrick Ott

Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Meredith McKean

Aff6 0000 0001 2291 4776grid.240145.6Division of Cancer MedicineUniversity of Texas MD Anderson Cancer Center 77030 Houston TX USA

Taofeek Owonikoko

18Emory University School of Medicine, Atlanta, GA, USA

Hatem Soliman

Department of Breast Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Laura Chow

10University of Texas Austin, Austin, TX, USA

Jong Chul Park

1Massachusetts General Hospital, Boston, MA, USA

Christos Fountzilas

11Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Corey Whalen

12Oncorus, Inc, Cambridge, MA, USA

Adrienne Yanez

12Oncorus, Inc, Cambridge, MA, USA

Christopher Dupont

12Oncorus, Inc, Cambridge, MA, USA

Julia Auer

12Oncorus, Inc, Cambridge, MA, USA

Tooba Cheema

12Oncorus, Inc, Cambridge, MA, USA

John Goldberg

12Oncorus, Inc, Cambridge, MA, USA

Ted Ashburn

12Oncorus, Inc, Cambridge, MA, USA